CWM
BIIB icon

Concert Wealth Management’s Biogen BIIB Stock Holding History

Concert Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,872
Closed -$533K – 181
2017
Q1 		$533K Sell
1,872
-133
-7% -$37.6K 0.12% 232
2016
Q4 		$572K Sell
2,005
-1,592
-44% -$472K 0.13% 227
2016
Q3 		$1.13M Sell
3,597
-200
-5% -$59.2K 0.14% 191
2016
Q2 		$912K Buy
3,797
+1,127
+42% +$297K 0.12% 219
2016
Q1 		$697K Sell
2,670
-3,923
-60% -$1.04M 0.09% 272
2015
Q4 		$2.02M Buy
6,593
+1,577
+31% +$453K 0.27% 87
2015
Q3 		$1.46M Buy
5,016
+2,145
+75% +$708K 0.2% 127
2015
Q2 		$1.16M Sell
2,871
-26
-0.9% -$10.4K 0.15% 171
2015
Q1 		$741K Buy
2,897
+22
+0.8% +$8.67K 0.21% 135
2014
Q4 		$975K Buy
2,875
+1,633
+131% +$528K 0.15% 181
2014
Q3 		$411K Buy
1,242
+74
+6% +$24.4K 0.06% 314
2014
Q2 		$359K Buy
1,168
+32
+3% +$9.63K 0.04% 368
2014
Q1 		$335K Sell
1,136
-92
-7% -$29.2K 0.04% 376
2013
Q4 		$345K Sell
1,228
-314
-20% -$81.2K 0.04% 343
2013
Q3 		$369K Sell
1,542
-4
-0.3% -$895 0.05% 320
2013
Q2 		$335K Buy
+1,546
New +$330K 0.05% 315

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Concert Wealth Management's BIIB Position: Q2 2017 in Review

Concert Wealth Management sold out of Biogen (BIIB) in Q2 2017, closing a stake of 1,872 shares — an estimated $533K sold.

Concert Wealth Management first reported a position in BIIB in Q2 2013 and held it in 16 quarters. The position peaked at $2.02M in Q4 2015. 993 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • Concert Wealth Management reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
  • Concert Wealth Management sold 1,872 Biogen shares in Q2 2017, an estimated $533K.
  • Concert Wealth Management first reported a position in Biogen in Q2 2013 and held it in 16 quarters.
  • Concert Wealth Management's Biogen position peaked at $2.02M in Q4 2015.
  • 993 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Concert Wealth Management's 13F filing for Q2 2017, filed 10 Aug 2017.